Biomarker Investigation Using Multiple Brain Measures from MRI Through Explainable Artificial Intelligence in Alzheimer’s Disease Classification
As the leading cause of dementia worldwide, Alzheimer’s Disease (AD) has prompted significant interest in developing Deep Learning (DL) approaches for its classification. However, it currently remains unclear whether these models rely on established biological indicators. This work compares a novel...
Saved in:
Main Authors: | Davide Coluzzi, Valentina Bordin, Massimo W. Rivolta, Igor Fortel, Liang Zhan, Alex Leow, Giuseppe Baselli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/12/1/82 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroimaging Findings of Psychosis in Alzheimer's Disease: A Systematic Review
by: Fardin Nabizadeh, et al.
Published: (2025-01-01) -
Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum
by: Han Zhao, et al.
Published: (2025-02-01) -
Peering into the Heart: A Comprehensive Exploration of Semantic Segmentation and Explainable AI on the MnMs-2 Cardiac MRI Dataset
by: Ayoob Mohamed, et al.
Published: (2025-01-01) -
MRI findings in patients with psychogenic non‐epileptic seizures: Prevalence, distribution, and classification of the findings. A single tertiary epilepsy center experience
by: Aleix Jareno‐Badenas, et al.
Published: (2025-02-01) -
Lipids and C-reactive protein predict anhedonia and reward circuit functional connectivity responses to anti-cytokine and dopaminergic therapies in patients with depression
by: Aditya Singh, et al.
Published: (2025-02-01)